Regeneron Pharmaceuticals (REGN) Current Deferred Tax Assets (2012 - 2015)

Regeneron Pharmaceuticals' Current Deferred Tax Assets history runs 4 years deep, the most recent figure standing at $60.5 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 23.5% year-over-year to $60.5 million; the TTM figure through Sep 2015 stood at $60.5 million (up 23.5% YoY), while the FY2014 annual figure was $46.2 million, up 3.36% from the prior year.
• Current Deferred Tax Assets was $60.5 million for Q3 2015 at Regeneron Pharmaceuticals, down from $69.6 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $148.1 million in Q4 2012 to a low of $36.6 million in Q1 2014.
• Historically, Current Deferred Tax Assets has averaged $61.0 million across 4 years, with a median of $47.6 million in 2014.
• The sharpest annual moves came in 2013 and 2015: Current Deferred Tax Assets sank 69.84% in 2013, then jumped 86.65% in 2015.
• A 4-year view of Current Deferred Tax Assets shows it stood at $148.1 million in 2012, then sank by 69.84% to $44.7 million in 2013, then gained by 3.36% to $46.2 million in 2014, then soared by 31.06% to $60.5 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $60.5 million (Q3 2015), $69.6 million (Q2 2015), and $62.1 million (Q1 2015), per Business Quant data.